CWM
ACAD icon

CIBC World Markets’s Acadia Pharmaceuticals ACAD Stock Holding History

CIBC World Markets’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$220K Buy
+8,234
New +$197K ﹤0.01% 1079
2025
Q2 		$331K Sell
15,335
-11,219
-42% -$209K ﹤0.01% 1060
2025
Q1 		$441K Buy
26,554
+15,355
+137% +$279K ﹤0.01% 1065
2024
Q4 		$206K Buy
+11,199
New +$181K ﹤0.01% 1118

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

CIBC World Markets's ACAD Position: Q4 2025 in Review

CIBC World Markets opened a new position in Acadia Pharmaceuticals (ACAD) in Q4 2025: 8,234 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #1079 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in ACAD as recently as Q2 2025.

CIBC World Markets first reported a position in ACAD in Q4 2024 and has held it in 4 quarters since. The position peaked at $441K in Q1 2025. 334 funds tracked by Wall St. Rank hold ACAD as of Q4 2025.

  • CIBC World Markets held 8,234 shares of Acadia Pharmaceuticals worth $220K as of Q4 2025.
  • Acadia Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Acadia Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1079 holding.
  • CIBC World Markets first reported a position in Acadia Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Acadia Pharmaceuticals position peaked at $441K in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.